Has an important test been overlooked? Closure flexibility in schizophrenia.

Schizophrenia Research
Pamela D ButlerDaniel C Javitt

Abstract

Deficits in visual processing are now recognized as a core feature of schizophrenia. In the 1940s, Louis Thurstone developed a series of tests designed to evaluate specific aspects of visual perceptual processing including the Closure Flexibility Test (CFT), which was designed to measure "the ability to hold a configuration in mind despite distraction." The present study evaluated patients' performance on this task and its relationship to other tests of neuropsychological function, particularly to a measure of sustained visual attention. Thirty-nine patients with schizophrenia or schizoaffective disorder and 40 controls participated. The CFT was administered both in its original form (10 min) and also in a briefer form (3 min) in which only a portion of stimuli were given. Patients showed highly significant large effect-size deficits on both the original (d=1.6) and brief (d=1.2) CFT. Between-group deficits in performance survived co-variation for IQ. In addition, the CFT score was significantly related to performance on the MATRICS measure of attention/vigilance, the Continuous Performance Test-Identical Pairs version (CPT-IP). This correlation remained significant even after controlling for non-specific intercorrelations amon...Continue Reading

References

Jan 1, 1972·Psychopharmacologia·P S Holzman
Jul 1, 1984·Journal of Clinical Psychology·T G Crookes
Jul 1, 1984·British Journal of Pharmacology·F Andreasen, J H Christensen
Nov 14, 1997·Acta Psychiatrica Scandinavica·J Peuskens, C G Link
Oct 30, 1998·Journal of Psychiatric Research·M D Jibson, R Tandon
Jun 26, 2003·The Journal of Clinical Psychiatry·Scott W Woods
Mar 31, 2004·Biological Psychiatry·Dwight DickinsonJames M Gold
Aug 5, 2004·Neuropsychology·Szabolcs KériZoltán Janka
Nov 9, 2004·Schizophrenia Research·Robert S KernBi-Hong Deng
Jul 13, 2005·Psychophysiology·Anthony J RisslingKeith H Nuechterlein
Nov 5, 2005·Neuron·Steven Dakin, Uta Frith
Jul 17, 2007·Biological Psychiatry·Zainab DelawallaDeanna M Barch
Jun 14, 2008·Biological Psychiatry·Pamela D ButlerSteven C Dakin

❮ Previous
Next ❯

Citations

Oct 11, 2012·PloS One·Rainer KraehenmannMichael Kometer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here